TRAF2 Exerts Opposing Effects on Basal and TNFα-induced Activation of the Classic IKK Complex in Hematopoietic Cells in Mice

Overview

Journal J Cell Sci

Specialty Cell Biology

Date 2016 Feb 14

PMID 26872784

Citations 5

Authors

Laiqun Zhang

Ken Blackwell

Lauren M Workman

Katherine N Gibson-Corley

Alicia K Olivier

Gail A Bishop

Hasem Habelhah

Affiliations

Soon will be listed here.

Abstract

The role of TRAF2 and TRAF5 in TNFα-induced NF-κB activation has become complicated owing to the accumulation of conflicting data. Here, we report that 7-day-old TRAF2-knockout (KO) and TRAF2 TRAF5 double KO (TRAF2/5-DKO) mice exhibit enhanced canonical IκB kinase (IKK) and caspase-8 activation in spleen and liver, and that subsequent knockout of TNFα suppresses the basal activity of caspase-8, but not of IKK. In primary TRAF2 KO and TRAF2/5-DKO cells, TNFα-induced immediate IKK activation is impaired, whereas delayed IKK activation occurs normally; as such, owing to elevated basal and TNFα-induced delayed IKK activation, TNFα stimulation leads to significantly increased induction of a subset of NF-κB-dependent genes in these cells. In line with this, both TRAF2 KO and TRAF2/5-DKO mice succumb to a sublethal dose of TNFα owing to increased expression of NF-κB target genes, diarrhea and bradypnea. Notably, depletion of IAP1 and IAP2 (also known as BIRC2 and BIRC3, respectively) also results in elevated basal IKK activation that is independent of autocrine TNFα production and that impairs TNFα-induced immediate IKK activation. These data reveal that TRAF2, IAP1 and IAP2, but not TRAF5, cooperatively regulate basal and TNFα-induced immediate IKK activation.

Citing Articles

Molecular signatures in prion disease: altered death receptor pathways in a mouse model.

Giri R J Transl Med. 2024; 22(1):503.

PMID: 38802941 PMC: 11129387. DOI: 10.1186/s12967-024-05121-x.

Screening for Femoral Head Osteonecrosis Following COVID-19: Is It Worth It?.

Dolat Abadi H, Parsa A, Stelzer J, Anz A, Ebrahimzadeh M, Bagheri F Arch Bone Jt Surg. 2023; 11(12):731-737.

PMID: 38146516 PMC: 10748811. DOI: 10.22038/ABJS.2023.73742.3414.

A data-driven computational model enables integrative and mechanistic characterization of dynamic macrophage polarization.

Zhao C, Medeiros T, Sove R, Annex B, Popel A iScience. 2021; 24(2):102112.

PMID: 33659877 PMC: 7895754. DOI: 10.1016/j.isci.2021.102112.

Role of inflammatory microenvironment: potential implications for improved breast cancer nano-targeted therapy.

Lan M, Lu W, Zou T, Li L, Liu F, Cai T Cell Mol Life Sci. 2021; 78(5):2105-2129.

PMID: 33386887 PMC: 11073202. DOI: 10.1007/s00018-020-03696-4.

Complete Acid Ceramidase ablation prevents cancer-initiating cell formation in melanoma cells.

Lai M, Realini N, La Ferla M, Passalacqua I, Matteoli G, Ganesan A Sci Rep. 2017; 7(1):7411.

PMID: 28785021 PMC: 5547127. DOI: 10.1038/s41598-017-07606-w.

References

Hoffmann A, Leung T, Baltimore D . Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities. EMBO J. 2003; 22(20):5530-9. PMC: 213788. DOI: 10.1093/emboj/cdg534. View

Zarnegar B, Yamazaki S, He J, Cheng G . Control of canonical NF-kappaB activation through the NIK-IKK complex pathway. Proc Natl Acad Sci U S A. 2008; 105(9):3503-8. PMC: 2265190. DOI: 10.1073/pnas.0707959105. View

Habelhah H . Emerging complexity of protein ubiquitination in the NF-κB pathway. Genes Cancer. 2010; 1(7):735-747. PMC: 2990976. DOI: 10.1177/1947601910382900. View

Zhang L, Blackwell K, Thomas G, Sun S, Yeh W, Habelhah H . TRAF2 suppresses basal IKK activity in resting cells and TNFalpha can activate IKK in TRAF2 and TRAF5 double knockout cells. J Mol Biol. 2009; 389(3):495-510. PMC: 2730456. DOI: 10.1016/j.jmb.2009.04.054. View

Nakajima A, Komazawa-Sakon S, Takekawa M, Sasazuki T, Yeh W, Yagita H . An antiapoptotic protein, c-FLIPL, directly binds to MKK7 and inhibits the JNK pathway. EMBO J. 2006; 25(23):5549-59. PMC: 1679768. DOI: 10.1038/sj.emboj.7601423. View

Bradley J, Pober J . Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene. 2001; 20(44):6482-91. DOI: 10.1038/sj.onc.1204788. View

Blackwell K, Zhang L, Workman L, Ting A, Iwai K, Habelhah H . Two coordinated mechanisms underlie tumor necrosis factor alpha-induced immediate and delayed IκB kinase activation. Mol Cell Biol. 2013; 33(10):1901-15. PMC: 3647962. DOI: 10.1128/MCB.01416-12. View

Vince J, Wong W, Khan N, Feltham R, Chau D, Ahmed A . IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell. 2007; 131(4):682-93. DOI: 10.1016/j.cell.2007.10.037. View

Ventura J, Kennedy N, Lamb J, Flavell R, Davis R . c-Jun NH(2)-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor. Mol Cell Biol. 2003; 23(8):2871-82. PMC: 152565. DOI: 10.1128/MCB.23.8.2871-2882.2003. View

10.

Haas T, Emmerich C, Gerlach B, Schmukle A, Cordier S, Rieser E . Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell. 2009; 36(5):831-44. DOI: 10.1016/j.molcel.2009.10.013. View

11.

Chen Z, Sun L . Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell. 2009; 33(3):275-86. DOI: 10.1016/j.molcel.2009.01.014. View

12.

Zhang L, Blackwell K, Shi Z, Habelhah H . The RING domain of TRAF2 plays an essential role in the inhibition of TNFalpha-induced cell death but not in the activation of NF-kappaB. J Mol Biol. 2010; 396(3):528-39. PMC: 2822030. DOI: 10.1016/j.jmb.2010.01.008. View

13.

Wong W, Gentle I, Nachbur U, Anderton H, Vaux D, Silke J . RIPK1 is not essential for TNFR1-induced activation of NF-kappaB. Cell Death Differ. 2009; 17(3):482-7. DOI: 10.1038/cdd.2009.178. View

14.

Mahoney D, Cheung H, Mrad R, Plenchette S, Simard C, Enwere E . Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc Natl Acad Sci U S A. 2008; 105(33):11778-83. PMC: 2575330. DOI: 10.1073/pnas.0711122105. View

15.

Nguyen L, Duncan G, Mirtsos C, Ng M, Speiser D, Shahinian A . TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses. Immunity. 1999; 11(3):379-89. DOI: 10.1016/s1074-7613(00)80113-2. View

16.

Vince J, Pantaki D, Feltham R, Mace P, Cordier S, Schmukle A . TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis. J Biol Chem. 2009; 284(51):35906-15. PMC: 2791019. DOI: 10.1074/jbc.M109.072256. View

17.

Workman L, Habelhah H . TNFR1 signaling kinetics: spatiotemporal control of three phases of IKK activation by posttranslational modification. Cell Signal. 2013; 25(8):1654-64. PMC: 3824607. DOI: 10.1016/j.cellsig.2013.04.005. View

18.

Alvarez S, Harikumar K, Hait N, Allegood J, Strub G, Kim E . Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature. 2010; 465(7301):1084-8. PMC: 2946785. DOI: 10.1038/nature09128. View

19.

Yin Q, Lamothe B, Darnay B, Wu H . Structural basis for the lack of E2 interaction in the RING domain of TRAF2. Biochemistry. 2009; 48(44):10558-67. PMC: 2830148. DOI: 10.1021/bi901462e. View

20.

Yamamoto M, Okamoto T, Takeda K, Sato S, Sanjo H, Uematsu S . Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nat Immunol. 2006; 7(9):962-70. DOI: 10.1038/ni1367. View